Potentiating Activity of GmhA Inhibitors on Gram-Negative Bacteria

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Antimicrobial Research

Background:

• Bacterial heptose biosynthesis is a potential target for novel antimicrobial therapies.
• The enzyme GmhA catalyzes the first committed step in heptose biosynthesis, utilizing a Zn²⁺ ion in its active site.

Purpose of the Study:

• To design and synthesize novel inhibitors targeting the GmhA enzyme.
• To evaluate the inhibitory potential and mechanism of action of these compounds against GmhA and bacterial growth.

Main Methods:

• Design and synthesis of phosphoryl- and phosphonyl-substituted hydroxamate derivatives.
• High-resolution crystal structure analysis of GmhA complexed with inhibitors.
• In vitro assays to determine GmhA inhibition, lipopolysaccharide heptosylation, cytotoxicity, and antibiotic potentiation.

Main Results:

• Several hydroxamate derivatives were synthesized and characterized.
• Crystal structures confirmed inhibitor binding to the Zn²⁺ active site of GmhA.
• Nanomolar inhibition of GmhA was achieved; compounds inhibited lipopolysaccharide heptosylation and potentiated antibiotics in *Escherichia coli*.

Conclusions:

• Hydroxamate-based inhibitors are effective against GmhA and bacterial lipopolysaccharide heptosylation.
• These compounds represent a promising new strategy for developing treatments against Gram-negative bacterial infections.
• Further development could lead to novel antimicrobial agents to combat resistant bacterial strains.